As China embraces AI, only 24% of US pharma execs bet on it for drug-making

SCMP Tech (AI)en

SCMP Tech (AI)

AI Global Wire

Pharmaceutical companies have embraced artificial intelligence in drug research almost universally, yet few company executives expect AI to actually make drugs succeed, according to a Citi survey ...

This is a short summary published by AI Global Wire. The full article is owned and hosted by SCMP Tech (AI) — open it there to read it in full.

Read the full story at SCMP Tech (AI)
  • Forskning

Related AI news